Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Köhrmann, Andrea ^a   Kammerer, Ulrike ^a   Kapp, Michaela ^a   Dietl, Johannes ^a   Anacker, Jelena ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 23; MATRIX METALLOPROTEINASE 24; MATRIX METALLOPROTEINASE 27; MATRIX METALLOPROTEINASE 28; MESSENGER RNA; NEUTROPHIL COLLAGENASE; STROMELYSIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER TISSUE; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST; BREAST TUMOR; ENZYMOLOGY; FEMALE; GENETICS; MIDDLE AGED; TUMOR CELL LINE;

AGED; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 67651071905     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-188     Document Type: Article

References (56)

1. Tyczynski JE Bray F Parkin DM Breast cancer in Europe ENCR Cancer Fact Sheets 2002:2.
2. Nagase H Visse R Murphy G Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 2006, 69(3):562-73. 10.1016/ j.cardiores.2005.12.002 16405877
3. Page-McCaw A Ewald AJ Werb Z Matrix metalloproteinases and the regulation of tissue remodelling Nat Rev Mol Cell Biol 2007, 8:211-233. 10.1038/nrm2125
4. Stamenkovic I Matrix metalloproteinases in tumor invasion and metastasis Semin Cancer Biol 2000, 10:415-433. 10.1006/scbi.2000.0379 11170864
5. Garbett EA Reed MWR Stephenson TJ Brown NJ Proteolysis in human breast cancer J Clin Pathol, Mol Pathol 2000, 53:99-106. 10.1136/mp.53.2.99
6. Curran S Dundas SR Buxton J Leeman MF Ramsay R Murray GI Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers Clin Cancer Res 2004, 10:8229-8234. 10.1158/1078-0432.CCR-04-0424 15623598
7. Forget MA Desrosiers RR Beliveau R Physiological roles of matrix metalloproteinases: Implications for tumor growth and metastasis Can J Physiol Pharm 1999, 77:465-480. 10.1139/cjpp-77-7-465
8. Duffy MJ Maguire TM Hill A McDermott E O'Higgins N Metalloproteinases: role in breast carcinogenesis, invasion and metastasis Breast Cancer Res 2000, 2(4):252-7. 138784 11250717 10.1186/bcr65
9. Gimbernardi TA Grant GM Taylor GP Hay RJ Maher VM Mc Cormick JJ Klebe RJ Overview of matrix metalloproteinase expression in cultured human cells Matrix Biol 1998, 16:483-96. 10.1016/S0945-053X(98)90019-1 9550265
10. Iwasaki M Nishikawa A Fujimoto T Akutagawa N Manase K Endo T Yoshida K Maekawa R Yoshioka T Kudo R Anti-invasive Effect of MMI-166 New Selective Matrix Metalloproteinase Inhibitor, in Cervical Carcinoma Cell Lines Gynecol Oncol 2002, 85:103-107. 10.1006/gyno.2001.6573 11925127
11. Kato Y Yamashita T Ishikawa M Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells Oncol Rep 2002, 9:565-569. 11956628
12. Talvensaari-Mattila A Pääkkö P Höyhtyä M Blanco-Sequeiros G Turppnniemi Hujanen T Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma Cancer 1998, 83:1153-62. 10.1002/ (SICI)1097-0142(19980915)83:6<1153::AID-CNCR14>3.0.CO;2-4 9740080
13. Li HC Cao DC Liu Y Hou YF Wu J Lu JS Di GH Liu G Li FM Ou ZL Jie C Shen ZZ Shao ZM Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma Breast Cancer Res Treat 2004, 88:75-85. 10.1007/s10549-004-1200-8 15538048
14. Mitropoulou TN Tzanakakis GN Kletsas D Kalofonos HP Karamanos NK Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells Int J Cancer 2003, 104(2):155-60. 10.1002/ijc.10941 12569569
15. Vizoso FJ Gonzales LO Corte MD Rodriguez JC Vazquez J Lamelas ML Junquera S Merino AM Garcia-Muniz JL Study of matrix metalloproteinases and their inhibitors in breast cancer Br J Cancer 2007, 96:903-911. 10.1038/sj.bjc.6603666 17342087
16. Kossakowska AE Huchcroft SA Urbanski SJ Edwards DR Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans Br J Cancer 1996, 73:1401. 8645587
17. Decock J Hendrickx W Frijkoningen M Wildiers H Neven P Smeets A Paridaens R Matrix metalloproteinase expression patterns in luminal A type breast carcinoma Dis Markers 2007, 23189-96. 17473389
18. Gonzalez LO Corte MD Vazquez J Junquera S Sanchez R Alvarez AC Rodriguez JC Lamelas ML Visoso FJ Androgen receptor expression in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors BMC Cancer 2008, 8:149. 2416360 18507821 10.1186/1471-2407-8-149
19. Pacheco MM Mourao M Mantovani EB Nishimoto IN Brentani MM Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: Clinico-pathological correlations Clin Exp Metastasis 1998, 16:577-585. 10.1023/A:1006580415796 9932604
20. Przybylowska K Kluczna A Zadrozny M Krawczyk T Kulig A Rykala J Kolacinska A Morawiec Z Drezewoski J Blasiak J Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer Breast Cancer Res Treat 2006, 95:65-72. 10.1007/ s10549-005-9042-6 16267613
21. Haupt LM Irving RE Weinstein SR Irving MG Griffiths LR Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material Mol Cell Probes 2008, 22(2):83-89. 10.1016/ j.mcp.2007.06.009 17669621
22. Ueno H Nakamura H Inoue M Imai K Noguchi M Sato H Seiki M Okada Y Expression and Tissue Localization of Membrane-Types 1, 2 and 3 Matrix Metalloproteinases in Human Invasive Breast Carcinomas Cancer Res 1997, 57:2055-2060. 9158005
23. Bartsch JE Staren ED Appert HE Matrix Metalloproteinase Expression in Breast Cancer J Surg Res 2003, 11:383-392. 10.1016/S0022-4804(03)00007-6
24. Bachmeier BE Nerlich AG Lichtinghagen R Sommerhoff CP Matrix Metalloproteinases (MMPs) in Breast Cancer Cell Lines of Different Tumorigenicity Anticancer Res 2001, 21:3821-3828. 11911253
25. Stark AM Anuszkiewicz B Mentlein R Yoneda T Mehdorn HM Held-Feindt J Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells J Neurooncol 2007, 81:39-48. 10.1007/s11060-006-9207-0 16850107
26. Haupt LM Thompson EW Trezise AE Irving RE Irving MG Griffiths LR In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts BMC Cancer 2006, 6:18. 1397851 16430785 10.1186/1471-2407-6-18
27. Balduyck M Zerimech F Gouyer V Lemaire R Hemon B Grard G Thiebaut C Lemaire V Dacquembronne E Duhem T Lebrun A Dejonghe MJ Huet G Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro Clin Exp Metastasis 2000, 18:171-178. 10.1023/A:1006762425323 11235993
28. Cell lines service Database http://cell-lines-service.de/content/ index_ger.html
29. Thompson EW Paik S Brunner N Sommers CL Zugmaier G Clarke R Shima TB Torri J Donahue S Lippman ME Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines J Cell Physiol 1992, 150:534-544. 10.1002/jcp.1041500314 1537883
30. Shafie SM Liotta LA Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice Cancer Lett 1980, 11:81-87. 10.1016/ 0304-3835(80)90097-X 6450636
31. Mukhopadhyay R Theriault RL Price JE Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells Clin Exp Metastasis 1999, 17:325-332. 10.1023/ A:1006659230585 10545019
32. Sheikh MS Shao ZM Hussain A Fontana J The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma Cancer Res 1993, 53:3226-3228. 8324731
33. Maemura M Akiyama SK Woods VLJ Dickson RB Expression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells Clin Exp Metastasis 1995, 13:223-235. 10.1007/BF00133478 7606885
34. Hall RE Lee CS Alexander IE Shine J Clarke CL Sutherland RL Steroid hormone receptor gene expression in human breast cancer cells: Inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels Int J Cancer 1990, 46:1081-1087. 10.1002/ijc.2910460622 2249895
35. Tong D Czerwenka K Sedlak J Schneeberger C Schiebel I Concin N Leodolter S Zeillinger R Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines Breast Cancer Res Treat 1999, 56:91-97. 10.1023/A:1006262501062 10517346
36. Thompson EW Paik S Brünner N Sommers CL Zugmaier G Clarke R Shima TB Torri J Donahue S Lippman ME Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines J Cell Physiol 1992, 150(3):534-544. 10.1002/jcp.1041500314 1537883
37. Janssens N Janicot M Perera T Bakker A Housekeeping genes as internal standards in cancer research Mol Diagn 2004, 8(2):107-113. 10.2165/ 00066982-200408020-00005 15527325
38. Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 1976, 72:. 248-54 10.1016/0003-2697(76)90527-3 942051
39. Labjournal http://www.laborjournal.de/rubric/tricks/tricks/trick81.html
40. Saez RA McGuire WL Clark GM Progonstic factors in breast cancer Semin Surg Onco 1989, 52:5198-5203.
41. Iwata H Kobayashi S Iwase H Masaoka A Fujimoto N Okada Y Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas Jpn J Cancer Res 1996, 87:602-611. 8766524
42. Heppner KJ Matrisian LM Jensen RA Rodgers WH Expression of most matrix metalloproteinase family members in breast cancer represents a tumor induced host response Am J Pathol 1996, 149:273-282. 1865221 8686751
43. Gutiérrez-Fernández A Fueyo A Folgueras AR Garabaya C Pennington CJ Pilgrim S Edwards DR Holliday DL Jones JL Span PN Sweep FC Puente XS López-Otín C Matrix metalloproteinase-8 functions as metastasis suppressor through modulation of tumor cell adhesion and invasion Cancer Res 2008, 68(8):2755-63. 10.1158/ 0008-5472.CAN-07-5154 18413742
44. Duffy MJ Blaser J Duggan C McDermott E O'Higgins N Fennelly JJ Tschesche H Assay of matrix metalloproteinase type 8 and 9 by ELISA in human breast cancer Br J Cancer 1995, 71:1025-8. 7734294
45. Zhang B Cao X Liu Y Cao W Zhang F Zhang S Li H Ning L Fu L Niu Y Niu R Sun B Hao X Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor Prognoses of invasive breast cancer BMC Cancer 2008, 8:83. 2362123 18373849 10.1186/1471-2407-8-83
46. Talvensaari-Mattila A Pääkkö P Blanco-Sequeiro G Turpeenniemi-Hujanen T Matrix metalloproteinase-2 (MMP2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy Breast Cancer Res Treat 2001, 65:55-61. 10.1023/A:1006458601568 11245340
47. Jones JL Glynn P Walker RA Expression of MMP-2 and MMP-9, their inhibitors and the activator MT1-MMP in primary breast carcinomas J Pathol 1999, 189:161-168. 10.1002/ (SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2 10547569
48. Rhako E Jukkola A Melkko J Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy Anticancer Res 2004, 24:4247-4254. 15736480
49. Ip YC Cheung ST Fan ST Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma Mol Carcinog 2007, 46(3):225-30. 10.1002/ mc.20270 17219425
50. Lengyel E Schmalfeldt B Konik E Späthe K Härting K Fenn A Berger U Fridman R Schmitt M Prechtel D Kuhn W Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer Gynecol Oncol 2001, 82(2):291-8. 10.1006/gyno.2001.6243 1153128
51. Djonov V Hogger K Sedlacek R Laissue J Draeger A MMP-19: Cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumors J Pathol 2001, 195:147-155. 10.1002/path.927 11592092
52. Sternlicht MD Werb Z How matrix metalloproteinases regulate cell behaviour Annu Rev Cell Dev Biol 2001, 17:463-516. 10.1146/ annurev.cellbio.17.1.463 11687497
53. Savinov AY Remacle AG Golubkov VS Krajewska M Kennedy S Duffy MJ Rozanov DV Krajewski S Strongin AY Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients Cancer Res 2006, 66(5):2716-24. 10.1158/0008-5472.CAN-05-3592 16510592
54. Grant GM Gimbernardi TA Grant AM Klebe RJ Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells Matrix Biol 1999, 18:145-148. 10.1016/S0945-053X(99)00003-7 10372554
55. Kousidou OC Roussidis AE Theocharis AD Karamanos NK Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential Anticancer Res 2004, 24(6):4025-30. 15739263
56. Vihinen P Kahari VM Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets Int J Cancer 2002, 99:157-166. 10.1002/ ijc.10329 11979428